388 related articles for article (PubMed ID: 29307099)
1. Boolean network modeling in systems pharmacology.
Bloomingdale P; Nguyen VA; Niu J; Mager DE
J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):159-180. PubMed ID: 29307099
[TBL] [Abstract][Full Text] [Related]
2. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
3. Boolean Modeling in Quantitative Systems Pharmacology: Challenges and Opportunities.
Putnins M; Androulakis IP
Crit Rev Biomed Eng; 2019; 47(6):473-488. PubMed ID: 32421972
[TBL] [Abstract][Full Text] [Related]
4. Boolean modeling in systems biology: an overview of methodology and applications.
Wang RS; Saadatpour A; Albert R
Phys Biol; 2012 Oct; 9(5):055001. PubMed ID: 23011283
[TBL] [Abstract][Full Text] [Related]
5. From data to QSP models: a pipeline for using Boolean networks for hypothesis inference and dynamic model building.
Putnins M; Campagne O; Mager DE; Androulakis IP
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):101-115. PubMed ID: 34988912
[TBL] [Abstract][Full Text] [Related]
6. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
7. Advanced Boolean modeling of biological networks applied to systems pharmacology.
Irurzun-Arana I; Pastor JM; Trocóniz IF; Gómez-Mantilla JD
Bioinformatics; 2017 Apr; 33(7):1040-1048. PubMed ID: 28073755
[TBL] [Abstract][Full Text] [Related]
8. Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities.
Bradshaw EL; Spilker ME; Zang R; Bansal L; He H; Jones RDO; Le K; Penney M; Schuck E; Topp B; Tsai A; Xu C; Nijsen MJMA; Chan JR
CPT Pharmacometrics Syst Pharmacol; 2019 Nov; 8(11):777-791. PubMed ID: 31535440
[TBL] [Abstract][Full Text] [Related]
9. Network based elucidation of drug response: from modulators to targets.
Iorio F; Saez-Rodriguez J; di Bernardo D
BMC Syst Biol; 2013 Dec; 7():139. PubMed ID: 24330611
[TBL] [Abstract][Full Text] [Related]
10. Continuous time Boolean modeling for biological signaling: application of Gillespie algorithm.
Stoll G; Viara E; Barillot E; Calzone L
BMC Syst Biol; 2012 Aug; 6():116. PubMed ID: 22932419
[TBL] [Abstract][Full Text] [Related]
11. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
12. Boolean modeling techniques for protein co-expression networks in systems medicine.
Mayer G; Marcus K; Eisenacher M; Kohl M
Expert Rev Proteomics; 2016 Jun; 13(6):555-69. PubMed ID: 27105325
[TBL] [Abstract][Full Text] [Related]
13. Discrete dynamic modeling of signal transduction networks.
Saadatpour A; Albert R
Methods Mol Biol; 2012; 880():255-72. PubMed ID: 23361989
[TBL] [Abstract][Full Text] [Related]
14. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
15. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
17. Towards patient stratification and treatment in the autoimmune disease lupus erythematosus using a systems pharmacology approach.
Ruiz-Cerdá ML; Irurzun-Arana I; González-Garcia I; Hu C; Zhou H; Vermeulen A; Trocóniz IF; Gómez-Mantilla JD
Eur J Pharm Sci; 2016 Oct; 94():46-58. PubMed ID: 27080094
[TBL] [Abstract][Full Text] [Related]
18. Systems pharmacology - Towards the modeling of network interactions.
Danhof M
Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
[TBL] [Abstract][Full Text] [Related]
19. Network-based drugs and biomarkers.
Erler JT; Linding R
J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
[TBL] [Abstract][Full Text] [Related]
20. Transforming Boolean models to continuous models: methodology and application to T-cell receptor signaling.
Wittmann DM; Krumsiek J; Saez-Rodriguez J; Lauffenburger DA; Klamt S; Theis FJ
BMC Syst Biol; 2009 Sep; 3():98. PubMed ID: 19785753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
